[EN] QUINUCLIDINONE ANALOGUES AS ANTICANCER AGENTS<br/>[FR] ANALOGUES DE QUINUCLIDINONE UTILISÉS EN TANT QU'AGENTS ANTICANCÉREUX
申请人:NEWAVE PHARMACEUTICAL INC
公开号:WO2022204109A1
公开(公告)日:2022-09-29
The disclosure includes compounds of either Formula (A), wherein R1, R2, R3, R4, m, n, k, r, s, t, and L are defined herein; or Formula (I), wherein R1, R2, R3, m, n, and k are defined herein. Also disclosed is a method for treating a neoplastic disease, autoimmune disease, and inflammatory disorder with these compounds.
该披露涉及以下公式的化合物:公式(A)中的R1、R2、R3、R4、m、n、k、r、s、t和L在此处定义;或公式(I)中的R1、R2、R3、m、n和k在此处定义。还披露了使用这些化合物治疗肿瘤性疾病、自身免疫性疾病和炎症性疾病的方法。